VASODILATATION OR LOOP-DIURETICS FOR INITIAL TREATMENT OF PULMONARY CONGESTION DUE TO ACUTE HEART FAILURE

Phase 4, randomised, double-blind trial in Acute Heart Failure (AHF) and pulmonary edema comparing Initial vasodilator therapy (Isoket) with Initial loop diuretic therapy (furosemide) (2 arms). Primary endpoint: Days alive and outside hospital until day 30. Planned start Jun 2022; status: authorised.